News

Study identifies possible bipolar I subtype with externalizing features


 

References

Bipolar disorder might include a distinct subphenotype characterized by externalizing symptoms and specific genetic variations, report Shanker Swaminathan, Ph.D., and his colleagues.

A study of 2,505 bipolar I disorder patients categorized participants into two groups: externalizing (those with comorbid externalizing disorders, plus a subgroup of patients with externalizing symptoms before 15 years of age) and nonexternalizing, wrote Dr. Swaminathan, formerly with the department of medical and molecular genetics at Indiana University, Indianapolis, and now with Baylor College of Medicine, Houston.

wildpixel/Thinkstock.com

Patients in the externalizing group showed significant differences in clinical features from the nonexternalizing group in multiple areas, including earlier age of onset of bipolar disorder, depression, and mania (P less than .001).

Additionally, those in the externalizing group had a higher frequency of self-harm incidents (P less than .001) and suicide attempts (P less than .008). These patients also were more likely to report a history of rapid switching and cycling (P less than .001), the authors reported.

Genetic analysis found numerous “nominally associated” SNPs, though none reached genome-wide significance, Dr. Swaminathan and his colleagues reported.

The findings “suggest the presence of an externalizing disorder subphenotype within [bipolar I disorder] warranting further investigation,” they concluded.

Read the full study here: J Affect Disord. 2015 Jun;178:206-14.

mrajaraman@frontlinemedcom.com

Recommended Reading

Metabolic dysfunction markers found in bipolar patients
MDedge Psychiatry
Bipolar patients can be identified using ‘rule of three’
MDedge Psychiatry
Mobile interventions helpful for bipolar disorder in short term
MDedge Psychiatry
Study: Bipolar mothers’ interaction with infants weaker than unipolar mothers’
MDedge Psychiatry
Executive attention deficits often persist in euthymic bipolar disorder
MDedge Psychiatry
New atypical antipsychotic FDA approved for use in bipolar I and schizophrenia
MDedge Psychiatry
Ambition linked to increased creativity in bipolar patients
MDedge Psychiatry
Bipolar type I patients’ relatives lack brain connectivity disruptions
MDedge Psychiatry
Bipolar phenotype affects present, future self-image
MDedge Psychiatry
What to do when your depressed patient develops mania
MDedge Psychiatry